TaiRx Competitors and Similar CompaniesClear all

TaiRx's competitors and similar companies include Peloton Therapeutics, Puma Biotechnology, La Jolla Pharmaceutical Company and TOT BIOPHARM.
TaiRx
TaiRx
TaiRx (台睿生物科技股份有限公司) is a pharmaceutical company that focuses mainly on oncological research.
Peloton Therapeutics
Peloton Therapeutics
Peloton Therapeutics is involved in discovering and developing novel drugs for cancer treatments.
Puma Biotechnology
Puma Biotechnology
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
La Jolla Pharmaceutical Company
La Jolla Pharmaceutical Company
La Jolla Pharmaceutical is a biopharmaceutical company that is focused on innovative therapeutics for chronic organ failure and cancer.
TOT BIOPHARM
TOT BIOPHARM
TOT BIOPHARM is a biopharmaceutical company that develops oncology drugs and therapies.
Founding Date
Founding Date
2011
Founding Date
2011
Founding Date
2010
Founding Date
1989
Founding Date
2009
Type
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Taipei, TW HQ
Locations
Dallas, US HQ
San Francisco, US
Locations
Los Angeles, US HQ
Locations
San Diego, US HQ
San Diego, US
San Diego, US
Locations
Suzhou Shi, CN HQ
Employees
Employees
2117% increase
Employees
554% increase
Employees
27214% decrease
Employees
9047% decrease
Employees
611
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
136.8 m
Valuation ($)
171.2 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
NT$8.2m (FY, 2024)
Revenue (est.)
N/A
Revenue (est.)
$228.4m (FY, 2025)
Revenue (est.)
$75.7m (FY, 2021)
Revenue (est.)
N/A
Cost of goods
Cost of goods
NT$6.9m (FY, 2024)
Cost of goods
N/A
Cost of goods
$58.2m (FY, 2025)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
NT$1.3m (FY, 2024)
Gross profit
N/A
Gross profit
$170.2m (FY, 2025)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
(NT$138.8m) (FY, 2024)
Net income
($36.1m) (FY, 2018)
Net income
N/A
Net income
$19.7m (FY, 2021)
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 92.6m
Total funding raised
$ 172m
Total funding raised
$ 22.9m
Total funding raised
$ 108m
For sources of this data, please see the company profile

View Company Profiles

Peloton Therapeutics
HQ
Dallas, US

Peloton Therapeutics is involved in discovering and developing novel drugs for cancer treatments.

View company
Puma Biotechnology
HQ
Los Angeles, US
Employees
272↓ 14% decrease

Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.

View company
La Jolla Pharmaceutical Company
HQ
San Diego, US
Employees
90↓ 47% decrease

La Jolla Pharmaceutical is a biopharmaceutical company that is focused on innovative therapeutics for chronic organ failure and cancer.

View company
TOT BIOPHARM
HQ
Suzhou Shi, CN
Employees
611

TOT BIOPHARM is a biopharmaceutical company that develops oncology drugs and therapies.

View company